New hope for stomach and bowel cancers: first human trial launches
Disease control
Not yet recruiting
This study tests a new drug called DB-1324 in people with advanced stomach, bowel, or other gastrointestinal cancers that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 127 parti…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 29, 2026 11:29 UTC